Atlas Trials

Reactogenicity and Immunogenicity of Third Dose Vaccine Booster Following Two Doses of Inactivated Vaccines

Clinical trial NCT05095298 · UNKNOWN

Trial details

NCT number
NCT05095298
Sponsor
Huashan Hospital
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
COVID-19
Start date
2021-08-01
Primary completion
2022-03-15
Enrollment
400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.